drugset / Trial / NCT00537420
A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to determine the effect of nasal PYY3-36 on weight loss post 24 weeks of treatment.
Timeline
- Start
- 2007-10
- Primary completion
- 2008-07
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PEPTIDE YY HUMAN (3-36) | Peptide | 200 ug | Intranasal |
| Subject | PEPTIDE YY HUMAN (3-36) | Peptide | 400 ug | Intranasal |
| Subject | PEPTIDE YY HUMAN (3-36) | Peptide | 600 ug | Intranasal |
| Comparator | Sibutramine | Small molecule | 10 mg | — |